Zimmer Biomet Announces Webcast And Conference Call Of Fourth Quarter 2024 Financial Results
Date
1/16/2025 7:48:37 AM
(MENAFN- PR Newswire)
WARSAW,
Ind., Jan. 16, 2025 /PRNewswire/ -- Zimmer
Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its fourth quarter earnings conference call will be webcast on Thursday, February 6, 2025 at 8:30 a.m. ET.
A news release detailing the quarterly results will be made available that day at 6:30 a.m. ET.
The live Audio webcast can be accessed via Zimmer Biomet's Investor Relations website at .
It will be available for replay following the conference call.
Individuals in the U.S. and Canada who wish to dial into the conference call may do so by dialing (888) 204-4368 and using conference ID 5103691.
International callers should dial +1 (323) 994-2093 and use conference ID 5103691.
About Zimmer Biomet
Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We seamlessly transform the patient experience through our innovative products and suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence.
With 90+ years of trusted leadership and proven expertise, Zimmer Biomet is positioned to deliver the highest quality solutions to patients and providers. Our legacy continues to come to life today through our progressive culture of evolution and innovation.
For more information about our product portfolio, our operations in 25+ countries and sales in 100+ countries or about joining our team, visit
or follow on LinkedIn at
or X / Twitter at
.
| Media |
|
Investors |
|
| Heather Zoumas-Lubeski (445) 248-0577 [email protected] |
|
David DeMartino (646) 531-6115 [email protected]
Zach Weiner (908) 591-6955 [email protected] |
|
SOURCE Zimmer Biomet Holdings, Inc.
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE?
440k+
Newsrooms &
Influencers
9k+
Digital Media
Outlets
270k+
Journalists
Opted In
GET STARTED
MENAFN16012025003732001241ID1109097552
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.